---
title: "Elder Pharmaceuticals Ltd (ELDERPHARM) — Share Price, Financials & Analysis"
symbol: "ELDERPHARM"
company: "Elder Pharmaceuticals Ltd"
canonical: "https://tapetide.com/stocks/ELDERPHARM"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T19:16:09.132Z"
---

# Elder Pharmaceuticals Ltd (ELDERPHARM)

Canonical page: https://tapetide.com/stocks/ELDERPHARM

## Company

- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2000-04-19
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** elderindia.com

## About

Elder Pharmaceuticals Limited, incorporated in India, listed on the Bombay Stock Exchange Limited, and National Stock Exchange Limited, the company is engaged in deals in pharmaceuticals & related products

## Latest Price

## Key Insights

### Strengths

- Company has reduced debt.
- Stock is trading at 0.11 times its book value
- Debtor days have improved from 81.3 to 60.7 days.

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 9.95% over past five years.
- Company has a low return on equity of -9.04% over last 3 years.
- Contingent liabilities of Rs.161 Cr.
- Company's cost of borrowing seems high

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | -390% | — | — |
| revenue growth | -41% | 1% | 10% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 323 | 185 | 273 | 387 | 229 | 120 | 203 | 158 | 152 |
| Expenses | 283 | 128 | 229 | 354 | 240 | 637 | 233 | 188 | 164 |
| Operating Profit | 40 | 57 | 44 | 34 | -11 | -517 | -30 | -31 | -12 |
| OPM % | 12 | 31 | 16 | 9 | -5 | -430 | -15 | -19 | -8 |
| Other Income | 17 | -1 | 6 | 4 | 19 | 740 | 17 | 1 | 2 |
| Interest | 23 | 48 | 37 | 49 | 69 | 120 | 23 | 45 | 22 |
| Depreciation | 9 | 8 | 9 | 11 | 10 | 6 | 11 | 9 | 10 |
| Profit before tax | 26 | 1 | 4 | -23 | -72 | 96 | -47 | -84 | -43 |
| Tax % | 20 | -4 | 29 | 1 | 2 | 0 | 0 | 0 | 7 |
| Net Profit | 21 | 1 | 3 | -23 | -74 | 97 | -47 | -84 | -46 |
| EPS in Rs | 10.22 | 0.41 | 1.53 | -11.36 | -35.85 | 47.01 | -22.82 | -40.69 | -22.41 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 15m | Jun 2014 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 449 | 551 | 620 | 722 | 960 | 1329 | 1626 | 997 | 633 |
| Expenses | 371 | 446 | 538 | 599 | 789 | 1130 | 1354 | 1433 | 1222 |
| Operating Profit | 78 | 105 | 82 | 123 | 171 | 199 | 272 | -436 | -589 |
| OPM % | 17 | 19 | 13 | 17 | 18 | 15 | 17 | -44 | -93 |
| Other Income | 7 | 8 | 41 | 4 | 4 | 28 | 31 | 754 | 760 |
| Interest | 16 | 24 | 41 | 53 | 66 | 102 | 155 | 276 | 211 |
| Depreciation | 9 | 11 | 12 | 17 | 29 | 34 | 44 | 36 | 37 |
| Profit before tax | 61 | 79 | 70 | 57 | 80 | 92 | 104 | 6 | -77 |
| Tax % | 14 | 11 | 13 | 16 | 21 | 21 | 21 | 209 | — |
| Net Profit | 53 | 70 | 61 | 47 | 64 | 72 | 82 | -7 | -80 |
| EPS in Rs | 28.41 | 37.1 | 32.26 | 26.25 | 31.27 | 35.19 | 40.12 | -3.18 | -38.91 |
| Dividend Payout % | 9 | 7 | 8 | 11 | 10 | 9 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Jun 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 19 | 19 | 19 | 19 | 21 | 21 | 21 | 21 |
| Reserves | 305 | 346 | 373 | 462 | 610 | 680 | 749 | 753 |
| Borrowings | 237 | 342 | 499 | 574 | 832 | 1081 | 1344 | 848 |
| Other Liabilities | 113 | 91 | 122 | 138 | 279 | 219 | 380 | 667 |
| Total Liabilities | 673 | 798 | 1013 | 1192 | 1741 | 2000 | 2492 | 2288 |
| Fixed Assets | 140 | 169 | 171 | 490 | 648 | 706 | 691 | 707 |
| CWIP | 137 | 163 | 252 | 66 | 95 | 191 | 273 | 305 |
| Investments | 37 | 88 | 50 | 66 | 10 | 20 | 3 | 3 |
| Other Assets | 359 | 377 | 539 | 570 | 989 | 1082 | 1526 | 1273 |
| Total Assets | 673 | 798 | 1013 | 1192 | 1741 | 2000 | 2492 | 2288 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Jun 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 71 | 21 | 136 | -91 | 66 | 15 | 17 | 1175 |
| Cash from Investing Activity | -88 | -108 | -35 | -161 | -151 | -171 | -63 | -56 |
| Cash from Financing Activity | 38 | 110 | -34 | 184 | 273 | 43 | -4 | -676 |
| Net Cash Flow | 20 | 22 | 67 | -68 | 188 | -113 | -51 | 443 |
| Free Cash Flow | -30 | -44 | 34 | -241 | -149 | -171 | -95 | 1096 |
| CFO/OP | 91 | 29 | 177 | -66 | 49 | 18 | 15 | -272 |

### Ratios

| Item | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Jun 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 99 | 92 | 105 | 99 | 107 | 94 | 89 | 61 |
| Inventory Days | 154 | 115 | 107 | 151 | 189 | 155 | 107 | 73 |
| Days Payable | 65 | 45 | 39 | 40 | 37 | 47 | 53 | 55 |
| Cash Conversion Cycle | 189 | 162 | 172 | 210 | 259 | 202 | 144 | 79 |
| Working Capital Days | 158 | 140 | 163 | 186 | 112 | 140 | 93 | -97 |
| ROCE % | — | 16 | 12 | 12 | 12 | 12 | 13 | -4 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 6 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 19.53 | Sell |
| EMA (10) | 19.65 | Sell |
| SMA (20) | 20.49 | Sell |
| EMA (20) | 20.19 | Sell |
| SMA (50) | 21.26 | Sell |
| EMA (50) | 21.28 | Sell |
| SMA (100) | 22.76 | Sell |
| EMA (100) | 22.67 | Sell |
| SMA (200) | 25.5 | Sell |
| EMA (200) | 24.9 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 44.42 | Neutral |
| MACD (12,26,9) | -0.67 | Sell |
| Stochastic (14,3,3) | 19.26 | Buy |
| ADX (14) | 23.85 | Neutral |
| Williams %R (14) | -71.43 | Neutral |
| ATR (14) | 1.39 | High Volatility |
| ROC (12) | -7.84 | Sell |
| Stoch RSI (14) | 52.74 | Neutral |
| UO (7,14,28) | 48.17 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| — | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 5 Feb 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8F65C9B6_7D85_4F43_B4BE_FB7FDF0801D0_161808.pdf) |
| — | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 5 Feb 2016](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2016/2/8F65C9B6_7D85_4F43_B4BE_FB7FDF0801D0_161808.pdf) |
| — | [Outcome of Board Meeting 3 Feb 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=B434E46F_7B89_4220_9286_C21EE35E3B83_164015.pdf) |
| — | [Outcome of Board Meeting 3 Feb 2016](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2016/2/B434E46F_7B89_4220_9286_C21EE35E3B83_164015.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2013 from nse](https://archives.nseindia.com/annual_reports/AR_3093_ELDERPHARM_2012_2013_01012014104905.zip) |
| from nse | [Annual Report 2012 from nse](https://archives.nseindia.com/annual_reports/AR_ELDERPHARM_2011_2012_31122012035656.zip) |
| from nse | [Annual Report 2011 from nse](https://archives.nseindia.com/annual_reports/AR_ELDERPHARM_2010_2011_11052012052025.zip) |
| from nse | [Annual Report 2010 from nse](https://archives.nseindia.com/annual_reports/AR_ELDERPHARM_2009_2010_03092010120000.zip) |
| from bse | [Annual Report 2013 from bse](https://www.bseindia.com/bseplus/AnnualReport/532322/5323220613.pdf) |
| from bse | [Annual Report 2012 from bse](https://www.bseindia.com/bseplus/AnnualReport/532322/5323220312.pdf) |
| from bse | [Annual Report 2011 from bse](https://www.bseindia.com/bseplus/AnnualReport/532322/5323220311.pdf) |
| from bse | [Annual Report 2010 from bse](https://www.bseindia.com/bseplus/AnnualReport/532322/5323220310.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:16:09.132Z.